Last year a mysterious shipment was caught smuggling Coronavirus from Canada. It was traced to Chinese agents working at a Canadian lab. Subsequent investigation by GreatGameIndia linked the agents to Chinese Biological Warfare Program from where the virus is suspected to have leaked causing the Wuhan Coronavirus outbreak.
On June 13, 2012 a 60-year-old Saudi man was admitted to a private hospital in Jeddah, Saudi Arabia, with a 7-day history of fever, cough, expectoration, and shortness of breath. He had no history of cardiopulmonary or renal disease, was receiving no long-term medications, and did not smoke.
Egyptian virologist Dr. Ali Mohamed Zaki isolated and identified a previously unknown coronavirus from his lungs. After routine diagnostics failed to identify the causative agent, Zaki contacted Ron Fouchier, a leading virologist at the Erasmus Medical Center (EMC) in Rotterdam, the Netherlands, for advice.
Fouchier sequenced the virus from a sample sent by Zaki. Fouchier used a broad-spectrum “pan-coronavirus” real-time polymerase chain reaction (RT-PCR) method to test for distinguishing features of a number of known coronaviruses known to infect humans.
Coronavirus arrived at Canada’s NML Winnipeg facility on May 4, 2013 from the Dutch lab. The Canadian lab grew up stocks of the virus and used it to assess diagnostic tests being used in Canada. Winnipeg scientists worked to see which animal species can be infected with the new virus.
Research was done in conjunction with the Canadian Food Inspection Agency’s national lab, the National Centre for Foreign Animal Diseases which is housed in the same complex as the National Microbiology Laboratory.
NML has a long history of offering comprehensive testing services for coronaviruses. It isolated and provided the first genome sequence of the SARS coronavirus and identified another coronavirus NL63 in 2004.
The NML scientist who was escorted out of the Canadian lab along with her husband, another biologist, and members of her research team is believed to be a Chinese Bio-Warfare agent Xiangguo Qiu. Qiu was the head of the Vaccine Development and Antiviral Therapies Section in the Special Pathogens Program at Canada’s NML.
Xiangguo Qiu is an outstanding Chinese scientist born in Tianjin. She primarily received her medical doctor degree from Hebei Medical University in China in 1985 and came to Canada for graduate studies in 1996. Later on, she was affiliated with the Institute of Cell Biology and the Department of Pediatrics and Child Health of the University of Manitoba, Winnipeg, not engaged with studying pathogens.
Dr. Xiangguo Qiu, the Chinese Biological Warfare Agent working at the National Microbiology Laboratory, Canada
Dr. Xiangguo Qiu is married to another Chinese scientist – Dr. Keding Cheng, also affiliated with the NML, specifically the “Science and Technology Core”. Dr. Cheng is primarily a bacteriologist who shifted to virology. The couple is responsible for infiltrating Canada’s NML with many Chinese agents as students from a range of Chinese scientific facilities directly tied to China’s Biological Warfare Program, namely:
Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun
Center for Disease Control and Prevention, Chengdu Military Region
Wuhan Institute of Virology, Chinese Academy of Sciences, Hubei
Institute of Microbiology, Chinese Academy of Sciences, Beijing
Sources say Xiangguo Qiu and her husband Keding Cheng were escorted from the National Microbiology Lab in Winnipeg on July 5, 2019. Since then, the University of Manitoba has ended their appointments, reassigned her graduate students, and cautioned staff, students and faculty about traveling to China. (Governor General’s Innovation Awards)
All of the above four mentioned Chinese Biological Warfare facilities collaborated with Dr. Xiangguo Qiu within the context of Ebola virus, the Institute of Military Veterinary joined a study on the Rift Valley fever virus too, while the Institute of Microbiology joined a study on Marburg virus. Noticeably, the drug used in the latter study – Favipiravir – has been earlier tested successfully by the Chinese Academy of Military Medical Sciences, with the designation JK-05 (originally a Japanese patent registered in China already in 2006), against Ebola and additional viruses.
However, the studies by Dr. Qiu are considerably more advanced and apparently vital for the Chinese biological weapons development in case Coronavirus, Ebola, Nipah, Marburg or Rift Valley fever viruses are included therein.
The Canadian investigation is ongoing and questions remain whether previous shipments to China of other viruses or other essential preparations, took place from 2006 to 2018, one way or another.
Dr. Gary Kobinger, former chief of special pathogens (right), and Dr. Xiangguo Qiu, research scientist (second from right) met with Dr. Kent Brantly and Dr. Linda Mobula, assistant professor at Johns Hopkins School of Medicine and the physician who administered ZMapp to Brantly in Liberia when he was infected with Ebola during the 2014-16 outbreak. (Submitted by Health Canada)
Dr. Xiangguo Qiu also collaborated in 2018 with three scientists from the US Army Medical Research Institute of Infectious Diseases, Maryland, studying post-exposure immunotherapy for two Ebola viruses and Marburg virus in monkeys; a study supported by the US Defense Threat Reduction Agency.
The Wuhan Coronavirus
Dr. Xiangguo Qiu made at least five trips over the school year 2017-18 to the above mentioned Wuhan National Biosafety Laboratory of the Chinese Academy of Sciences, which was certified for BSL4 in January 2017. Moreover, in August 2017, the National Health Commission of China approved research activities involving Ebola, Nipah, and Crimean-Congo hemorrhagic fever viruses at the Wuhan facility.
Coincidentally, the Wuhan National Biosafety Laboratory is located only 20 miles away from the Huanan Seafood Market which is the epicenter of the Coronavirus outbreak dubbed the Wuhan Coronavirus.
The Wuhan National Biosafety Laboratory is housed at the Chinese military facility Wuhan Institute of Virology linked to China’s Biological Warfare Program. It was the first ever lab in the country designed to meet biosafety-level-4 (BSL-4) standards – the highest biohazard level, meaning that it would be qualified to handle the most dangerous pathogens.
In January 2018, the lab was operational ‘for global experiments on BSL-4 pathogens,’ wrote Guizhen Wu in the journal Biosafety and Health. ‘After a laboratory leak incident of SARS in 2004, the former Ministry of Health of China initiated the construction of preservation laboratories for high-level pathogens such as SARS, coronavirus, and pandemic influenza virus,’ wrote Guizhen Wu.
Coronavirus Bioweapon
The Wuhan institute has studied coronaviruses in the past, including the strain that causes Severe Acute Respiratory Syndrome, or SARS, H5N1 influenza virus, Japanese encephalitis, and dengue. Researchers at the institute also studied the germ that causes anthrax – a biological agent once developed in Russia.
“Coronaviruses (particularly SARS) have been studied in the institute and are probably held therein,” said Dany Shoham, a former Israeli military intelligence officer who has studied Chinese biowarfare. He said. “SARS is included within the Chinese BW program, at large, and is dealt with in several pertinent facilities.”
James Giordano, a neurology professor at Georgetown University and senior fellow in Biowarfare at the U.S. Special Operations Command, said China’s growing investment in bio-science, looser ethics around gene-editing and other cutting-edge technology and integration between government and academia raise the spectre of such pathogens being weaponized. E
That could mean an offensive agent, or a modified germ let loose by proxies, for which only China has the treatment or vaccine. “This is not warfare, per se,” he said. “But what it’s doing is leveraging the capability to act as global saviour, which then creates various levels of macro and micro economic and bio-power dependencies.”
China’s Biological Warfare Program
In a 2015 academic paper, Shoham – of Bar-Ilan’s Begin-Sadat Center for Strategic Studies – asserts that more than 40 Chinese facilities are involved in bio-weapon production.
China’s Academy of Military Medical Sciences actually developed an Ebola drug – called JK-05 — but little has been divulged about it or the defence facility’s possession of the virus, prompting speculation its Ebola cells are part of China’s bio-warfare arsenal, Shoham told the National Post.
Ebola is classified as a “category A” bioterrorism agent by the U.S. Centers for Disease Control and Prevention, meaning it could be easily transmitted from person to person, would result in high death rates and “might cause panic.” The CDC lists Nipah as a category C substance, a deadly emerging pathogen that could be engineered for mass dissemination.
China’s Biological Warfare Program is believed to be in an advanced stage that includes research and development, production and weaponization capabilities. Its current inventory is believed to include the full range of traditional chemical and biological agents with a wide variety of delivery systems including artillery rockets, aerial bombs, sprayers, and short-range ballistic missiles.
Weaponizing Biotech
China’s national strategy of military-civil fusion has highlighted biology as a priority, and the People’s Liberation Army could be at the forefront of expanding and exploiting this knowledge.
The PLA is pursuing military applications for biology and looking into promising intersections with other disciplines, including brain science, supercomputing, and artificial intelligence. Since 2016, the Central Military Commission has funded projects on military brain science, advanced biomimetic systems, biological and biomimetic materials, human performance enhancement, and “new concept” biotechnology.
In 2016, an AMMS doctoral researcher published a dissertation, “Research on the Evaluation of Human Performance Enhancement Technology,” which characterized CRISPR-Cas as one of three primary technologies that might boost troops’ combat effectiveness. The supporting research looked at the effectiveness of the drug Modafinil, which has applications in cognitive enhancement; and at transcranial magnetic stimulation, a type of brain stimulation, while also contending that the “great potential” of CRISPR-Cas as a “military deterrence technology in which China should “grasp the initiative” in development.
In 2016, the potential strategic value of genetic information led the Chinese government to launch the National Genebank, which intends to become the world’s largest repository of such data. It aims to “develop and utilize China’s valuable genetic resources, safeguard national security in bioinformatics, and enhance China’s capability to seize the strategic commanding heights” in the domain of Biotechnology Warfare.
Chinese military’s interest in biology as an emerging domain of warfare is guided by strategists who talk about potential “genetic weapons” and the possibility of a “bloodless victory.”
Coronavirus Bioweapon – How Chinese agents stole Coronavirus from Canada and weaponized it into a Bioweapon
Abnormalities on Chest Imaging of the Saudi patient infected with Coronavirus. Shown are chest radiographs of the patient on the day of admission (Panel A) and 2 days later (Panel B) and computed tomography (CT) 4 days after admission (Panel C).
This undated file image released by the British Health Protection Agency shows an electron microscope image of a coronavirus, part of a family of viruses that cause ailments including the common cold and SARS, which was first identified in the Middle East. HANDOUT/THE ASSOCIATED PRESS
The National Microbiology Lab (The Canadian Science Centre for Human and Animal Health) on Arlington St. in Winnipeg. Wayne Glowacki/Winnipeg Free Press Oct.22 2014
The Wuhan National Biosafety Laboratory is located just about 20 miles away from the Huanan Seafood Market, the epicenter of Coronavirus outbreak
